sales@angenesci.com
Login | Register
logo
Structures Search
Home Aminos 1-((3，4-Dimethoxyphenethyl)amino)-3-(m-tolyloxy)propan-2-ol hydrochloride

1-((3，4-Dimethoxyphenethyl)amino)-3-(m-tolyloxy)propan-2-ol hydrochloride

CAS No.:
42864-78-8
Catalog Number:
AG00BXT9
Molecular Formula:
C20H28ClNO4
Molecular Weight:
381.8936
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
98%(HPLC)
In Stock USA
United States
$73
- +
25mg
98%(HPLC)
In Stock USA
United States
$123
- +
100mg
98%(HPLC)
In Stock USA
United States
$175
- +
250mg
98%(HPLC)
In Stock USA
United States
$296
- +
1g
98%(HPLC)
In Stock USA
United States
$847
- +
Product Description
Catalog Number:
AG00BXT9
Chemical Name:
1-((3，4-Dimethoxyphenethyl)amino)-3-(m-tolyloxy)propan-2-ol hydrochloride
CAS Number:
42864-78-8
Molecular Formula:
C20H28ClNO4
Molecular Weight:
381.8936
MDL Number:
MFCD00941389
IUPAC Name:
1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol;hydrochloride
InChI:
InChI=1S/C20H27NO4.ClH/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3;/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3;1H
InChI Key:
FJTKCFSPYUMXJB-UHFFFAOYSA-N
SMILES:
COc1cc(CCNCC(COc2cccc(c2)C)O)ccc1OC.Cl
Properties
Complexity:
355  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
381.171g/mol
Formal Charge:
0
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
381.897g/mol
Monoisotopic Mass:
381.171g/mol
Rotatable Bond Count:
10  
Topological Polar Surface Area:
60A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Life sciences 20070712
Determination of bevantolol enantiomers in human plasma by coupled achiral-chiral high performance-liquid chromatography. Chirality 20070701
Determination of bevantolol in human plasma by high performance liquid chromatography using solid phase extraction technique. Archives of pharmacal research 20070701
Chiral purity test of bevantolol by capillaryelectrophoresis and high performance liquid chromatography. Archives of pharmacal research 20060901
Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy. Cardiology 20050101
Effect of beta-blockers on insulin resistance in patients with dilated cardiomyopathy. Circulation journal : official journal of the Japanese Circulation Society 20030801
Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy. Circulation journal : official journal of the Japanese Circulation Society 20021201
Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy. Heart and vessels 20021201
Bevantolol: a beta-1 adrenoceptor antagonist with unique additional actions. Journal of clinical pharmacology 19870701
Pharmacology of bevantolol hydrochloride. The American journal of cardiology 19861126
Properties